课题基金 / 基金详情

IN VITRO FIBRIL FORMATION BY MUTANT ALPHA SYNUCLEIN: PARKINSON DISEASE

IN VITRO FIBRIL FORMATION BY MUTANT ALPHA SYNUCLEIN: PARKINSON DISEASE
突变型α突触核蛋白的体外纤维形成:帕金森病
批准号:
6478956
负责人:
PETER T LANSBURY
金额:
$5.36万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-07-01 至 2002-06-30

项目摘要

项目成果

PETER T LANSBURY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Transmission of abused drugs to infants through drug use during pregnancy is being monitored in a state program that obtains meconium from newborns in hospitals selected to represent the various strata among the whole population. Unexpectedly high rates of positive results for tetrahydrocannabinoids has necessitated further analysis of the reserved remainder of thepreviously examined meconium samples to determine whether the standard method (FPIA) gives false positives. A mass spectrometric method was devised, similar to a published method, butmodified to handle stored samples. The mass spectrometric method indicated a lower overall rate. Results obtained have been verified by a commercial laboratory that specializes in this type of assay and further recently collected samples have been submitted for analysis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Facility for drug testing in alpha-syn transgenic drosophila & new models of PD
  • 批准号:
    7009789
  • 项目类别:
  • 资助金额:
    $8.57万
  • 财政年份:
    2005
  • 负责人:
    PETER T LANSBURY
  • 依托单位:
Discovery of highly toxic synuclein sequence variants
  • 批准号:
    7013561
  • 项目类别:
  • 资助金额:
    $8.54万
  • 财政年份:
    2005
  • 负责人:
    PETER T LANSBURY
  • 依托单位:
A High-Throughput Assay-SOD1 Aggregation Inhibitors(RMI)
  • 批准号:
    7022025
  • 项目类别:
  • 资助金额:
    $21.88万
  • 财政年份:
    2005
  • 负责人:
    PETER T LANSBURY
  • 依托单位:
Biochemistry of PD gene products
  • 批准号:
    7009781
  • 项目类别:
  • 资助金额:
    $38.26万
  • 财政年份:
    2005
  • 负责人:
    PETER T LANSBURY
  • 依托单位:
海外基金